<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37264854</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-3799</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical nursing research</Title><ISOAbbreviation>Clin Nurs Res</ISOAbbreviation></Journal><ArticleTitle>Clinical and Socio-Demographic Variables Associated With Long COVID-19: A Cross-Sectional Study.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>953</EndPage><MedlinePgn>947-953</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10547738231177395</ELocationID><Abstract><AbstractText>Considering the importance of long COVID-19 (LC), this study aimed to investigate the relationship between clinical/sociodemographic factors and LC symptoms (LCS). This online cross-sectional study was conducted on 308 people infected with COVID-19 in Alborz, Iran, from April 1 to June 1, 2022. Multivariable logistic regression models were applied to measure the association between the LCS with other variables. Overall, 76.6% of participants had at least one LCS. Results from the multivariate logistic regression analysis showed that females (crude odds ratio [OR] [95% confidence interval (CI)]: 2.725 [1.42, 5.22]), educated persons (3.747 [1.58, 8.84]), people with a higher number of COVID-19 reinfection (2.280 [1.30, 3.97]), having an underlying disease (1.996 [1.01, 3.93]), and COVID-19 severity (3.321 [1.037, 10.635]) had higher odds of LC than others (all <i>p</i>&#x2009;&lt;&#x2009;.05). Study findings provide additional clinical/sociodemographic data on risk for LC. These data may inform future research and clinical practice for potential risk identification and early intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahmoodi</LastName><ForeName>Zohreh</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahrami</LastName><ForeName>Giti</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahrestanaki</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seddighi</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child &amp; Family Welfare Unit, University of Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health in Disaster and Emergencies, Faculty of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghavidel</LastName><ForeName>Nooshin</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1511-3772</Identifier><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Nurs Res</MedlineTA><NlmUniqueID>9208508</NlmUniqueID><ISSNLinking>1054-7738</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000722979">COVID-19 reinfection</SupplMeshName></SupplMeshList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long-term symptoms</Keyword><Keyword MajorTopicYN="N">social determinants of health</Keyword><Keyword MajorTopicYN="N">socioeconomic status</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37264854</ArticleId><ArticleId IdType="pmc">PMC10240294</ArticleId><ArticleId IdType="doi">10.1177/10547738231177395</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aiyegbusi O. L., Hughes S. E., Turner G., Rivera S. C., McMullan C., Chandan J. S., Haroon S., Price G., Davies E. H., Nirantharakumar K., Sapey E., Calvert M. J.; TLC Study Group. (2021). Symptoms, complications and management of long COVID: A review. Journal of the Royal Society of Medicine, 114(9), 428&#x2013;442. 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. (2021). Post-covid syndrome in individuals admitted to hospital with covid-19: Retrospective cohort study. BMJ, 372, n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M. L., Catalfamo C. J., Farland L. V., Ernst K. C., Jacobs E. T., Klimentidis Y. C., Jehn M., Pogreba-Brown K. (2021). Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS One, 16(8), e0254347. 10.1371/journal.pone.0254347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., Gaudy-Graffin C., Grammatico-Guillon L., Bernard L. (2021). Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection, 27(2), 258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Clouston S. A., Natale G., Link B. G. (2021). Socioeconomic inequalities in the spread of coronavirus-19 in the United States: A examination of the emergence of social inequalities. Social Science &amp; Medicine, 268, 113554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703549</ArticleId><ArticleId IdType="pubmed">33308911</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvishpour J., Omidi S., Farmanbar R. J. C. (2016). The relationship between health literacy and hypertension treatment control and follow-up. Caspian Journal of Health Research, 2(1), 1&#x2013;8.</Citation></Reference><Reference><Citation>Desai A. D., Lavelle M., Boursiquot B. C., Wan E. Y. (2022). Long-term complications of COVID-19. American Journal of Physiology-Cell Physiology, 322(1), C1&#x2013;C11. 10.1152/ajpcell.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Emecen A. N., Keskin S., Turunc O., Suner A. F., Siyve N., Basoglu Sensoy E., Unal B. (2023). The presence of symptoms within 6 months after COVID-19: A single-center longitudinal study. Irish Journal of Medical Science (1971-), 192(2), 741&#x2013;750. 10.1007/s11845-022-03072-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-03072-0</ArticleId><ArticleId IdType="pmc">PMC9205653</ArticleId><ArticleId IdType="pubmed">35715663</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami A., Mahmoudi A., Khabiri M., Najafiyan Razavi S. M. (2014). The role of socioeconomic conditions in the citizens&#x2019; motivation for participating in public sports. Applied Research in Sport Management, 2(3), 89&#x2013;104.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J. D., Pellicer-Valero &#xd3;. J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M. L., Jos&#xe9; A., Arias-Naval&#xf3;n J. A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. (2022). Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM multicenter study. Journal of Clinical Medicine, 11(2), 413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a B. A., Lema E. R., Rabu&#xf1;al Rey R. R. (2022). Health perception among female COVID-19 patients. Comment on Fern&#xe1;ndez-de-las-Pe&#xf1;as et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM multicenter study. Journal of Clinical Medicine, 11, 413. 10.3390/jcm11112999</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11112999</ArticleId><ArticleId IdType="pmc">PMC9181377</ArticleId><ArticleId IdType="pubmed">35683388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Islas D., S&#xe1;nchez-Moreno C., Orea-Tejeda A., Hern&#xe1;ndez-L&#xf3;pez S., Salgado-Fern&#xe1;ndez F., Keirns-Davis C., Galicia-Amor S., Trejo-Mellado E., Gochicoa-Rangel L., Castorena-Maldonado A. (2022). Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections. BMC Pulmonary Medicine, 22(1), 223. 10.1186/s12890-022-02014-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02014-x</ArticleId><ArticleId IdType="pmc">PMC9175169</ArticleId><ArticleId IdType="pubmed">35676657</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R., Joseph P., Rosengren A., Yusuf S. J. (2022). Location and level of care, education, availability of medicines and cardiovascular mortality. In Fuster V. N. J., Vaishnava P., Leon M. B., Callans D. J., Rumsfeld J. S., Poppas A. (Eds.), Fuster &amp; hurst&#x2019;s: The heart (511&#x2013;526). McGraw Hill.</Citation></Reference><Reference><Citation>Hanson S. W., Abbafati C., Aerts J. G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., Buonsenso D., Butnaru D., Carter A., Chu H., De Rose C, Diab M. M., Ekbom E., El Tantawi M., Fomin V., . . .Vos T. (2022). A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv.</Citation></Reference><Reference><Citation>Iqbal F. M., Lam K., Sounderajah V., Clarke J. M., Ashrafian H., Darzi A. J. E. (2021). Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine, 36, 100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L. G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., Bawa H., Berrol L., Qureshi N., Aschner J. L. (2020). Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One, 15(12), e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Larijani M. S., Ashrafian F., Amiri F. B., Banifazl M., Bavand A., Karami A., Shokooh F. A., Ramezani A. (2022). Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran. Microbial Pathogenesis, 169, 105618. 10.1016/j.micpath.2022.105618</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105618</ArticleId><ArticleId IdType="pmc">PMC9176176</ArticleId><ArticleId IdType="pubmed">35690233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P. A., Cuapio A., Villapol S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Scientific Reports, 11(1), 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodi Z., Koshesh K. J., Almasi G., Pournajaf S., Rastad H., Ghavidel N. (2021). Association between structural determinants of health and posttraumatic stress symptoms during the COVID-19 pandemic. Current Psychiatry Research and Reviews Formerly: Current Psychiatry Reviews, 17(4), 270&#x2013;279.</Citation></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M. V., McGroder C., Stevens J. S. (2021). Post-acute COVID-19 syndrome. Nature Medicine, 27(4), 601&#x2013;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. (2021). COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence, London, UK. Retrieved November 11, 2021 from https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742</Citation></Reference><Reference><Citation>Ortona E., Buonsenso D., Carfi A., Malorni W. J. C. D. D. (2021). Long COVID: An estrogen-associated autoimmune disease? Cell Death Discovery, 7(1), 1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P. A., Majori M., Aiello M., Corradi M., Chetta A. (2022). Sex-related differences in long-COVID-19 syndrome. Journal of Women&#x2019;s Health, 31(5), 620&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E. D., Hishmeh L. (2021). Managing the long term effects of covid-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ, 372, n136.</Citation><ArticleIdList><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A. K., Gupta R., Baig V. N., Singh V. T., Chakraborty S., Sunda J. P., Dhakar P., Sharma S. P., Panwar R. B., Katoch V. M. (2022). Educational status and COVID-19 related outcomes in India: Hospital-based cross-sectional study. BMJ Open, 12(2), e055403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882634</ArticleId><ArticleId IdType="pubmed">35217540</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K. M., Taverner T., Chandan J. S., Brown K., Simms-Williams N., Shah A. D. (2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine, 28(8), 1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., . . .Canas L. S. (2021). Attributes and predictors of long COVID. Nature Medicine, 27(4), 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D. L., Holdsworth L., Jawad N., Gunasekera P., Morice A. H., Crooks M. G. (2021). Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung, 199(2), 113&#x2013;119. 10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E. J., Williams D. M., Walker A. J., Mitchell R. E., Niedzwiedz C. L., Yang T. C., . . .Steves C. J. (2022). Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications, 13(1), 3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases, 53(10), 737&#x2013;754. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>